Howard Marks's INDV Position Overview
Howard Marks (via Oaktree Capital Management Lp) currently holds 6.13 M shares of Indivior Pharmaceuticals, Inc. (INDV) worth $251.4 M, representing 3.49% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Howard Marks has maintained a strategic position in INDV, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 246.78 M shares. Largest reduction occurred in Q4 2025, reducing 250.68 M shares.
Analysis based on 13F filings available since 2013 Q2
Howard Marks's Indivior Pharmaceuticals (INDV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Indivior Pharmaceuticals (INDV) Trades by Howard Marks
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +6.13 M | New Buy | 6.13 M | $41.03 |
| Q1 2026 | -7.11 M | Sold Out | 0 | $0.00 |
| Q4 2025 | -250.68 M | Reduce 97.24% | 7.11 M | $35.88 |
| Q3 2025 | +246.78 M | Add 2241.56% | 257.79 M | $0.04 |
| Q1 2025 | +2.28 M | Add 26.06% | 11.01 M | $9.40 |
| Q4 2024 | -788,432 | Reduce 8.28% | 8.73 M | $12.82 |
| Q3 2024 | +5.03 M | Add 111.92% | 9.52 M | $9.88 |
| Q2 2024 | +1.14 M | Add 34.08% | 4.49 M | $15.67 |
| Q1 2024 | +3.35 M | New Buy | 3.35 M | $21.40 |
Howard Marks's Indivior Pharmaceuticals Investment FAQs
Howard Marks first purchased Indivior Pharmaceuticals, Inc. (INDV) in Q1 2024, acquiring 3,351,236 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Howard Marks has held Indivior Pharmaceuticals, Inc. (INDV) for 10 quarters since Q1 2024.
Howard Marks's largest addition to Indivior Pharmaceuticals, Inc. (INDV) was in Q3 2025, adding 257,785,398 shares worth $10.69 M.
According to the latest 13F filing for Q2 2026, Howard Marks's firm, Oaktree Capital Management Lp, owns 6,127,212 shares of Indivior Pharmaceuticals, Inc. (INDV), valued at approximately $251.4 M.
As of the Q2 2026 filing, Indivior Pharmaceuticals, Inc. (INDV) represents approximately 3.49% of Howard Marks's publicly disclosed stock portfolio, making it one of their key holdings.
Howard Marks's peak holding in Indivior Pharmaceuticals, Inc. (INDV) was 257,785,398 shares, as reported at the end of Q3 2025.